Investors Title Company
Financials
Valuation Metrics
Investors Title Company's Market Cap is $546M. At end of 2025 it was $471M. Ranked #2758 of 3,121 in US market (top 88%), #1197 of 1,463 on NASDAQ (top 82%), #86 of 93 in Insurance (top 92%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $546M | US#2,758/3,121 Sec#86/93 |
| Revenue | $293M | US#2,469/3,121 Sec#88/93 |
| Net Income | $40M | US#1,958/3,121 Sec#81/93 |
| Total Assets | $380M | US#2,863/3,121 Sec#93/93 |
| Net Assets | $287M | US#2,545/3,121 Sec#90/93 |
| Employees | 561 | US#2,237/3,121 Sec#74/93 |
| Value | ||
| P/E | 13.50x | US#681/3,121 Sec#59/93 |
| P/B | 1.90x | US#1,211/3,121 Sec#57/93 |
| PEG | 0.61x | US#693/3,121 Sec#50/93 |
| P/S | 1.86x | US#1,251/3,121 Sec#61/93 |
| EV/EBITDA | 9.11x | US#707/3,121 Sec#52/93 |
| FCF Yield | 5.36% | US#1,366/3,121 Sec#74/93 |
| Profitability | ||
| ROE | 14.11% | US#960/3,121 Sec#46/93 |
| ROA | 10.64% | US#438/3,121 Sec#8/93 |
| Op. Margin | 17.70% | US#1,043/3,121 Sec#37/93 |
| Revenue Growth | 8.67% | US#1,407/3,121 Sec#43/93 |
| Earnings Growth | 22.05% | US#823/3,121 Sec#50/93 |
| Financial Health | ||
| Debt Ratio | 32.65% | US#370/3,121 Sec#3/93 |
| Total Debt | $9M | US#2,853/3,121 Sec#90/93 |
| FCF | $29M | US#2,124/3,121 Sec#84/93 |
| Cash | $20M | US#2,866/3,121 Sec#91/93 |
| Current Ratio | 37.61x | US#69/3,121 Sec#13/93 |
| Net Debt/EBITDA | -0.20x | US#499/3,121 Sec#27/93 |
| Dividend | ||
| Div. Yield | 3.65% | US#486/3,121 Sec#17/93 |
| Div. Growth | -33.26% | US—/3,121 Sec—/93 |
| Performance | ||
| 1Y Return | 12.02% | US#1,218/3,121 Sec#33/93 |
| 1M Return | -1.16% | US#763/3,121 Sec#19/93 |
| From 52W High | -6.64% | US#259/3,121 Sec#19/93 |
| 1Y MDD | -26.86% | US#1,179/3,121 Sec#63/93 |
| Trading | ||
| Volume | 69,841 shares | US#3,076/3,121 Sec#91/93 |
| Trading Value | $20M | US#2,297/3,121 Sec#70/93 |
| Per Share | ||
| EPS | $21.41 | US#85/3,121 Sec#16/93 |
| BPS | $151.79 | US#43/3,121 Sec#9/93 |
Company Info
Investors Title Company (ITIC), along with its various subsidiaries, primarily specializes in providing title insurance for a diverse range of properties, including residential homes, commercial buildings, institutional facilities, and industrial sites. The company operates in a dual capacity within the title insurance market: it acts as a direct insurer for property owners and mortgage lenders, and it also functions as a reinsurer, assuming title insurance risks from other providers. Beyond its core insurance offerings, ITIC delivers specialized services related to tax-deferred exchanges of like-kind property. In this area, it serves as a qualified intermediary, skillfully managing the complexities of these transactions. This involves preparing necessary exchange documents, securely holding exchange funds during the transition between property sales and new acquisitions, and facilitating the proper identification of replacement properties. Furthermore, ITIC takes on the role of an exchange accommodation titleholder, particularly for "reverse exchanges" where a replacement property is acquired before the relinquished property is sold. The company also extends its expertise to investment management and trust services, catering to a broad clientele that includes individuals, corporations, banks, and various trusts. Additionally, it offers consulting and management guidance to assist clients in the establishment and operation of their own title insurance agencies. ITIC's title insurance policies are distributed through a dual network comprising approved attorneys working from its underwriting offices, as well as independent issuing agents. This extensive network spans 24 states and the District of Columbia, with its primary geographical focus being the eastern half of the United States. Established in 1972, Investors Title Company maintains its corporate headquarters in Chapel Hill, North Carolina.